KREMEN2 and non-small cell lung carcinoma: In this study, Kremen2 was highly expressed in LUAD according to the TCGA clinical data analysis (Fig. 1B), while the bioinformatics analysis from the GEPIA database further confirmed the high expression of Kremen2 in NSCLC (Fig. 1C).